Journal Title：Chinese Clinical Oncology

Chinese Clinical Oncology mainly reports on the latest developments, advances, and technologies in the field of oncology at home and abroad, aiming to provide a platform for global oncology researchers to communicate and share, and promote the development and progress of oncology. The magazine focuses on reporting the latest research achievements and progress in the field of oncology at home and abroad, especially new concepts, technologies, and methods in the diagnosis, treatment, prevention, and rehabilitation of tumors. At the same time, the journal also focuses on hot topics and cutting-edge fields in oncology research, such as tumor immunotherapy, gene therapy, molecular targeted therapy, etc. The readership mainly includes medical professionals engaged in oncology research, clinical diagnosis and treatment, and teaching both domestically and internationally, as well as researchers and students interested in oncology. By reading this magazine, readers can learn about the latest developments and trends in the field of oncology, and improve their professional competence and clinical skills.

《中國臨床腫瘤學》主要報道國內外腫瘤學領域的新動態、新進展和新技術，旨在為全球的腫瘤學研究者提供一個交流和分享的平臺，促進腫瘤學的發展和進步。雜志注重報道國內外腫瘤學領域的最新研究成果和進展，特別是在腫瘤的診斷、治療、預防和康復等方面的新理念、新技術和新方法。同時，該雜志還關注腫瘤學研究的熱點問題和前沿領域，如腫瘤免疫治療、基因治療、分子靶向治療等。讀者群體主要包括國內外從事腫瘤學研究、臨床診療和教學的醫學工作者，以及對腫瘤學感興趣的科研人員和學生。通過閱讀該雜志，讀者可以了解到腫瘤學領域的最新動態和發展趨勢，提高自己的專業素養和臨床技能。

Chinese Clinical Oncology由AME Publishing Company出版商出版，收稿方向涵蓋ONCOLOGY全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發表機率較高。平均審稿速度 ，影響因子指數2.1，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。